
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SPIRIVA | Boehringer Ingelheim | N-021395 RX | 2004-01-30 | 1 products, RLD, RS |
| SPIRIVA RESPIMAT | Boehringer Ingelheim | N-021936 RX | 2014-09-24 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| STIOLTO RESPIMAT | Boehringer Ingelheim | N-206756 RX | 2015-05-21 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| spiriva | New Drug Application | 2025-11-10 |
| spiriva respimat | New Drug Application | 2025-11-25 |
| stiolto respimat | New Drug Application | 2025-06-30 |
| tiotropium bromide | ANDA | 2025-11-11 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| chronic bronchitis | — | D029481 | J42 |
| pulmonary emphysema | — | D011656 | J43 |
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Olodaterol Hydrochloride / Tiotropium Bromide, Stiolto Respimat, Boehringer Ingelheim | |||
| 8733341 | 2030-10-16 | DP | |
| 7837235 | 2028-03-13 | DP | |
| 9027967 | 2027-03-31 | DP | |
| 7727984 | 2027-01-19 | DP | |
| 7396341 | 2026-10-10 | DP | |
| 7220742 | 2025-05-12 | DS, DP | U-1703 |
| 8034809 | 2025-05-12 | U-1702 | |
| Tiotropium Bromide, Spiriva, Boehringer Ingelheim | |||
| 8022082 | 2026-01-19 | DP | U-1186 |
| Tiotropium Bromide, Spiriva Respimat, Boehringer Ingelheim | |||
| 7896264 | 2025-05-26 | DP | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 1 | — | — | 1 |
| Obstructive lung diseases | D008173 | — | — | — | — | 1 | — | — | 1 |
| Drug common name | Tiotropium |
| INN | tiotropium bromide |
| Description | Tiotropium bromide is an organic bromide salt having (1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane as the counterion. Used (in the form of the hydrate) for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease. It has a role as a bronchodilator agent and a muscarinic antagonist. It is an organic bromide salt and a quaternary ammonium salt. |
| Classification | Small molecule |
| Drug class | quaternary ammonium derivatives; atropine derivatives |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21 |
| PDB | — |
| CAS-ID | 186691-13-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1900528 |
| ChEBI ID | — |
| PubChem CID | 5487426 |
| DrugBank | DBSALT000348 |
| UNII ID | XX112XZP0J (ChemIDplus, GSRS) |











